February 13, 2014 I Kissei Pharmaceutical Co., Ltd. [Head Office: Matsumoto-city, Nagano, Japan; President and CEO: Mutsuo Kanzawa] today announced that Kissei has entered into a business collaboration agreement with Alteogen Inc. [Head Office: Yuseong-gu, Daejeon, South Korea; President and CEO: Soon Jae Park], a bio-venture company. Under the agreement, Kissei underwrites the allocation of new shares to a third party from Alteogen, and start a collaborative research for biosimilar.
Through this business collaboration with Alteogen, Kissei will continue to further strengthen its efforts to biopharmaceutical business.
The impact from this agreement will be immaterial in the fiscal year ended on March 31, 2014.
SOURCE: Kissei Pharmaceutical Co
Post Views: 409
February 13, 2014 I Kissei Pharmaceutical Co., Ltd. [Head Office: Matsumoto-city, Nagano, Japan; President and CEO: Mutsuo Kanzawa] today announced that Kissei has entered into a business collaboration agreement with Alteogen Inc. [Head Office: Yuseong-gu, Daejeon, South Korea; President and CEO: Soon Jae Park], a bio-venture company. Under the agreement, Kissei underwrites the allocation of new shares to a third party from Alteogen, and start a collaborative research for biosimilar.
Through this business collaboration with Alteogen, Kissei will continue to further strengthen its efforts to biopharmaceutical business.
The impact from this agreement will be immaterial in the fiscal year ended on March 31, 2014.
SOURCE: Kissei Pharmaceutical Co
Post Views: 409
